Arteriovenous Malformation Market Dynamics: Supply, Demand, and Innovation
The Arteriovenous Malformation Market is driven by the interplay of demand, supply, and technological innovation. Rising prevalence of AVM cases is increasing the need for advanced treatment options, while suppliers focus on developing minimally invasive devices and embolic agents.
Innovations in imaging, robotics, and radiosurgery devices are improving treatment outcomes, reducing procedural risks, and expanding adoption in hospitals and specialty clinics worldwide.
Market Outlook: Valued at USD 1.1 billion in 2024, the market is expected to reach USD 2.4 billion by 2034, at a 7.0% CAGR.
2 Views